Drug Substance

Drug Substance refers to the active pharmaceutical ingredient containing the intended therapeutic effect, representing the biologically or chemically active component that is formulated into the final drug product. In biologics, drug substance may include purified monoclonal antibodies, recombinant proteins, viral vectors, or other active biomolecules produced through upstream and downstream manufacturing processes. Drug substance quality attributes must be defined, controlled, and consistently achieved to ensure safety and efficacy.

The pharmaceutical industry distinguishes drug substance from drug product because each stage requires different controls, specifications, and regulatory documentation. Drug substance manufacturing includes raw material qualification, process control, purification, and extensive analytical characterisation confirming identity, purity, potency, and stability. Storage conditions, container closure systems, and transport requirements are validated to prevent degradation before formulation and fill-finish operations. Regulatory submissions include detailed drug substance descriptions, control strategies, and stability data supporting shelf-life and supply reliability. As novel modalities expand, drug substance definitions and control expectations continue evolving to address increased complexity while ensuring consistent therapeutic performance.